Abstract

Dr. Neha Patil*, Dr. Nagendra Thakre, Dr. Megha Agrawal and Dr. Ankita Agrawal

ABSTRACT

70-80% neonates presentwith some percentage of hyperbilirubinemia, after birth jaundice is the common morbidity in the neonatal, period, however only 7-12% would require therapy to prevent damage or treat the cause of neonatal jaundice. Neonatal jaundice can be mainly classified physiological pathological jaundice. Increased bilirubin production, reduced hepatic clearance and enhanced enterohepatic circulation are the sole causes of increased prevalence of jaundice in new born. Phototherapy is accepted as the primary treatment of Hyper bilirubinaemia. This treatment also puts the baby at risk of important complications including retinal injury, dehydration, diarrhoea and bronze baby syndrome. Therefore, searches in order to reduce the time of phototherapy by a safer treatment have been considered for many years.